Application of Personalized Palliative Care in Patients With Newly Diagnosed Idiopathic Pulmonary Fibrosis

NCT06714188 | Completed

• 1 other identifier: IPF-PPC
• Study Type: observational
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to develop a tool that helps the medical-nursing team in the identification of the real palliative care needs of each individual patient. Patients with newly diagnosed Idiopathic Pulmonary Fibrosis will be asked just a few simple questions in order to place them at the most appropriate level of palliative care (PC) even before the first medical contact. This would not only optimize resource allocation (e.g., allowing patients with low palliative needs to be assessed solely by the PC nurse), but also benefit patients who have difficulty leaving their homes by enabling them to receive evaluation and palliative care directly at home rather than after a hospital assessment.

Conditions

IPF

Keywords

Questionnaire; Palliative Care; IPF

Outcome Measures

Primary Outcomes (1)

• Evaluation of concordance between the levels of palliative care obtained using a triage questionnaire and those derived from the clinical judgments of the dedicated pulmonologist and the dedicated palliative care physician

  The primary objective will be measured by calculating Krippendorff's alpha coefficient of reliability among the classifications obtained with the questionnaire, the clinical judgment of the pulmonologist, and the clinical judgment of the palliative care physician

  18 months

Secondary Outcomes (1)

• Description of the degree of palliative care needs that patients with IPF present when referred to the reference pulmonology center

  18 months

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with a diagnosis of Idiopathic Pulmonary Fibrosis (IPF) established after discussion at the Multidisciplinary Interstitial Disease Meeting and referred to the APPI Fibrosi unit of the IRCCS for specialized care

You may qualify if:

• Age ≥ 18 years.
• New diagnosis of Idiopathic Pulmonary Fibrosis (IPF) established through a Multidisciplinary Interstitial Disease Meeting.
• Obtaining written informed consent.

You may not qualify if:

• Patient's inability to understand and/or respond to the questions in the questionnaire as judged by the healthcare provider.
• Patient already receiving care from the Palliative Care Service.

Sponsors & Collaborators

• IRCCS Azienda Ospedaliero-Universitaria di Bologna: lead

Study Sites (1)

IRCCS Azienda Ospedaliera-Universitaria di Bologna

Bologna, Bologna, 40138, Italy

Location

Study Officials

• Stefano Nava, MD

  IRCCS Azienda Ospedaliero-Universitaria di Bologna

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 28, 2024
• First Posted: December 3, 2024
• Study Start: September 19, 2023
• Primary Completion: July 17, 2024
• Study Completion: June 30, 2025
• Last Updated: March 2, 2026

Record last verified: 2026-01

Locations

IT (1)